Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer
Researchers from Chiba University, Medical Department detail findings in cancer
March 12th, 2009
According to recent research from Chiba, Japan, "The current study examined the clinical usefulness of YKL-40 in detection and prognosis of uterine cervical cancer. Serum levels of YKL-40, cancer antigen 125 (CA 125), carbohydrate antigen 19-9 (CA19-9), and squamous cell carcinoma (SCC) antigen were determined by enzyme-linked immunosorbent assay in women with benign gynecologic disease (n = 24), cervical malignancy (SCC, n = 104; adenocarcinoma, n = 37), and age-matched healthy controls (n = 45)." "Immunohistochemical analysis for local YKL-40 expression was carried out on 28 adenocarcinomas. Receiver operating characteristic curve analysis showed that YKL-40 [area...
Source: Women's Health Weekly (2009-03-12)
|
